Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine in COVID-19 Pneumonia
NCT04322565Phase 2Completed
- Sponsor
- Azienda Ospedaliero-Universitaria di Parma
- Start
- Apr 2020
- Primary completion
- Sep 2021
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of colchicine in COVID-19 pneumonia, sponsored by Azienda Ospedaliero-Universitaria di Parma. Started Apr 2020; status: completed.
02
Drugs
colchicine
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04322565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04322565.